MiNK Therapeutics stock price
NASDAQ:INKT · Nasdaq · Healthcare · sector #16MiNK Therapeutics's chart data is dated 2026-10-21. Recorded technical signals: Mean reversion. There are 2 published signal records.
MiNK Therapeutics last closed at $10.62 (+7.71%) on 2026-10-21. Signals today: Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -4.7×. Its overall grade ranks 69 of 727 stocks in Healthcare.
About this company
MiNK Therapeutics last closed at $10.62 (+7.71%) on 2026-10-21. Signals today: Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A+ · 69/727
Valuation grade A+
Related stocks
- AstraZenecaCustomer
- Bristol Myers SquibbCustomer
- Merck & CoCustomer
About MiNK Therapeutics
- What technical signals does MiNK Therapeutics (INKT) have?
- MiNK Therapeutics current technical signals: Mean reversion.
- Is MiNK Therapeutics a cup-and-handle pattern?
- No. MiNK Therapeutics has no valid Cup signal right now.
- What published figures are available for MiNK Therapeutics?
- Market cap: $49.85M. Trailing 12 months PER: -4.7×. Latest quarter PBR: -3.80×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about MiNK Therapeutics, or open the plan table on the main site.
Ask Q about MiNK Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.